255 related articles for article (PubMed ID: 30016448)
1. Anaplastic Large Cell Lymphoma Manifesting as Pleural Effusion in a Patient with Long-Standing Eosinophilia.
Belludi CK; Qian ET; Tolle JJ; Brown RM; Thompson MA; Juskevicius R
Lab Med; 2019 Jan; 50(1):87-92. PubMed ID: 30016448
[TBL] [Abstract][Full Text] [Related]
2. Pathology and genetics of anaplastic large cell lymphoma.
Leventaki V; Bhattacharyya S; Lim MS
Semin Diagn Pathol; 2020 Jan; 37(1):57-71. PubMed ID: 31882178
[TBL] [Abstract][Full Text] [Related]
3. ALCL by any other name: the many facets of anaplastic large cell lymphoma.
Irshaid L; Xu ML
Pathology; 2020 Jan; 52(1):100-110. PubMed ID: 31706671
[TBL] [Abstract][Full Text] [Related]
4. Cytological features of breast implant-associated anaplastic large cell lymphoma in pleural effusion.
D'Alessandris N; Lucatelli P; Tripodi D; Amabile MI; Ascoli V
Diagn Cytopathol; 2019 Nov; 47(11):1213-1217. PubMed ID: 31348611
[TBL] [Abstract][Full Text] [Related]
5. How to Diagnose Anaplastic Large Cell Lymphoma on Cytological Samples? A Series with Emphasis on Diagnostic Clue and Pitfalls.
Montella M; LucĂ S; Ronchi A; Marino FZ; Caputo A; Sica A; Zeppa P; Franco R; Cozzolino I
Acta Cytol; 2023; 67(3):230-239. PubMed ID: 36634640
[TBL] [Abstract][Full Text] [Related]
6. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
Xing X; Feldman AL
Adv Anat Pathol; 2015 Jan; 22(1):29-49. PubMed ID: 25461779
[TBL] [Abstract][Full Text] [Related]
8. Systemic ALK-negative anaplastic large cell lymphoma with distinctive myxoid change and DUSP22 rearrangement.
Fratoni S; Trawinska MM; Capalbo A; Bernardini L; Fabbretti M; Martini M; Niscola P; Zhao XF
Virchows Arch; 2022 Dec; 481(6):975-979. PubMed ID: 35879438
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management.
Shustov A; Soma L
Cancer Treat Res; 2019; 176():127-144. PubMed ID: 30596216
[TBL] [Abstract][Full Text] [Related]
10. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
Oregel KZ; Everett E; Zhang X; Nagaraj G
Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
[TBL] [Abstract][Full Text] [Related]
12. Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphoma.
Yuan CT; Cheng AL; Hou HA
Virchows Arch; 2023 Mar; 482(3):641-645. PubMed ID: 35984488
[TBL] [Abstract][Full Text] [Related]
13. The clinicopathological relevance of uniform CD56 expression in anaplastic large cell lymphoma: a retrospective analysis of 18 cases.
Yu BH; Zhang Y; Xue T; Shui RH; Lu HF; Zhou XY; Zhu XZ; Li XQ
Diagn Pathol; 2021 Jan; 16(1):1. PubMed ID: 33402163
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic large cell lymphoma in leukemic phase: extraordinarily high white blood cell count.
Nguyen JT; Condron MR; Nguyen ND; De J; Medeiros LJ; Padula A
Pathol Int; 2009 May; 59(5):345-53. PubMed ID: 19432678
[TBL] [Abstract][Full Text] [Related]
15. Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment.
Zhang XR; Chien PN; Nam SY; Heo CY
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406421
[TBL] [Abstract][Full Text] [Related]
16. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
[TBL] [Abstract][Full Text] [Related]
17. Primary ALK-1-negative anaplastic large cell lymphoma of the brain: case report and review of the literature.
Kodama K; Hokama M; Kawaguchi K; Tanaka Y; Hongo K
Neuropathology; 2009 Apr; 29(2):166-71. PubMed ID: 18564100
[TBL] [Abstract][Full Text] [Related]
18. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma.
Ravindran A; Feldman AL; Ketterling RP; Dasari S; Rech KL; McPhail ED; Kurtin PJ; Shi M
Am J Surg Pathol; 2021 Apr; 45(4):550-557. PubMed ID: 33165091
[TBL] [Abstract][Full Text] [Related]
19. Systemic, primary cutaneous, and breast implant-associated ALK-negative anaplastic large-cell lymphomas present similar biologic features despite distinct clinical behavior.
Gerbe A; Alame M; Dereure O; Gonzalez S; Durand L; Tempier A; De Oliveira L; Tourneret A; Costes-Martineau V; Cacheux V; Szablewski V
Virchows Arch; 2019 Aug; 475(2):163-174. PubMed ID: 30953147
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]